Sickle Cell Disease
Markers of pulmonary impairment and inflammation were elevated in children with sickle cell disease and acute chest syndrome.
A FDA Advisory Committee endorsed the safety of exa-cel, a genetic therapy with the potential to cure sickle cell disease.
Oral deferiprone yielded outcomes comparable to subcutaneous deferoxamine for pediatric patients with sickle cell disease.
Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH.
Research showed the historical effect of pneumococcal conjugate vaccines on infections in children with sickle cell disease.
Stem cell gene therapy showed potential as a curative approach for the hereditary blood disorder sickle cell disease.
Pediatric patients with SCD undergoing orthopedic surgery are at an increased risk of perioperative complications.
In pediatric patients with sick cell disease, red blood cell transfusion increases alloimmunization.
A study investigated potential variations in pain trajectories based on sex and other factors in adolescents with SCD.
Psychosocial variables are more strongly associated with pain impact in individuals with SCD than biological variables.
Advertisement
Expert Interviews on Hematology
Advertisement
